nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—SSTR5—brainstem—germ cell cancer	0.0474	0.0718	CbGeAlD
Pasireotide—SSTR3—brainstem—germ cell cancer	0.0454	0.0688	CbGeAlD
Pasireotide—SSTR1—brainstem—germ cell cancer	0.0359	0.0544	CbGeAlD
Pasireotide—SSTR5—pituitary gland—germ cell cancer	0.0342	0.0519	CbGeAlD
Pasireotide—SSTR3—pituitary gland—germ cell cancer	0.0328	0.0497	CbGeAlD
Pasireotide—SSTR1—telencephalon—germ cell cancer	0.0319	0.0483	CbGeAlD
Pasireotide—SSTR2—brainstem—germ cell cancer	0.0305	0.0462	CbGeAlD
Pasireotide—SSTR2—eye—germ cell cancer	0.0297	0.045	CbGeAlD
Pasireotide—SSTR2—telencephalon—germ cell cancer	0.0271	0.041	CbGeAlD
Pasireotide—SSTR5—endocrine gland—germ cell cancer	0.0265	0.0402	CbGeAlD
Pasireotide—SSTR1—pituitary gland—germ cell cancer	0.0259	0.0393	CbGeAlD
Pasireotide—SSTR3—endocrine gland—germ cell cancer	0.0254	0.0385	CbGeAlD
Pasireotide—SSTR3—head—germ cell cancer	0.0251	0.038	CbGeAlD
Pasireotide—SSTR5—cerebellum—germ cell cancer	0.0234	0.0354	CbGeAlD
Pasireotide—SSTR1—midbrain—germ cell cancer	0.0229	0.0347	CbGeAlD
Pasireotide—SSTR3—cerebellum—germ cell cancer	0.0224	0.0339	CbGeAlD
Pasireotide—SSTR2—pituitary gland—germ cell cancer	0.0221	0.0334	CbGeAlD
Pasireotide—SSTR1—endocrine gland—germ cell cancer	0.0201	0.0304	CbGeAlD
Pasireotide—SSTR1—head—germ cell cancer	0.0198	0.0301	CbGeAlD
Pasireotide—SSTR3—brain—germ cell cancer	0.0182	0.0276	CbGeAlD
Pasireotide—SSTR1—cerebellum—germ cell cancer	0.0177	0.0268	CbGeAlD
Pasireotide—SSTR2—endocrine gland—germ cell cancer	0.0171	0.0259	CbGeAlD
Pasireotide—SSTR2—head—germ cell cancer	0.0169	0.0256	CbGeAlD
Pasireotide—SSTR2—cerebellum—germ cell cancer	0.0151	0.0228	CbGeAlD
Pasireotide—SSTR1—brain—germ cell cancer	0.0144	0.0218	CbGeAlD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.0139	0.0754	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.0134	0.0726	CbGpPWpGaD
Pasireotide—SSTR2—brain—germ cell cancer	0.0122	0.0185	CbGeAlD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.0114	0.0617	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.011	0.0594	CbGpPWpGaD
Pasireotide—Amylase increased—Cisplatin—germ cell cancer	0.00762	0.0491	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.00744	0.0403	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.00609	0.033	CbGpPWpGaD
Pasireotide—SSTR3—Peptide ligand-binding receptors—OXT—germ cell cancer	0.0057	0.0309	CbGpPWpGaD
Pasireotide—SSTR1—Peptide ligand-binding receptors—OXT—germ cell cancer	0.00546	0.0296	CbGpPWpGaD
Pasireotide—SSTR5—Peptide ligand-binding receptors—OXT—germ cell cancer	0.00484	0.0262	CbGpPWpGaD
Pasireotide—SSTR2—Peptide ligand-binding receptors—OXT—germ cell cancer	0.00447	0.0242	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.00438	0.0237	CbGpPWpGaD
Pasireotide—SSTR3—Peptide ligand-binding receptors—AVP—germ cell cancer	0.0039	0.0211	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.00382	0.0207	CbGpPWpGaD
Pasireotide—SSTR1—Peptide ligand-binding receptors—AVP—germ cell cancer	0.00374	0.0203	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.00366	0.0198	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.00359	0.0194	CbGpPWpGaD
Pasireotide—SSTR5—Peptide ligand-binding receptors—AVP—germ cell cancer	0.00332	0.018	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.00325	0.0176	CbGpPWpGaD
Pasireotide—SSTR2—Peptide ligand-binding receptors—AVP—germ cell cancer	0.00306	0.0166	CbGpPWpGaD
Pasireotide—Pain in extremity—Ifosfamide—germ cell cancer	0.00306	0.0197	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Dactinomycin—germ cell cancer	0.003	0.0194	CcSEcCtD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.003	0.0162	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—OXT—germ cell cancer	0.00291	0.0158	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—OXT—germ cell cancer	0.00279	0.0151	CbGpPWpGaD
Pasireotide—Hypokalaemia—Ifosfamide—germ cell cancer	0.00278	0.0179	CcSEcCtD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.00262	0.0142	CbGpPWpGaD
Pasireotide—Alopecia—Vinblastine—germ cell cancer	0.00259	0.0167	CcSEcCtD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.00251	0.0136	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—OXT—germ cell cancer	0.00247	0.0134	CbGpPWpGaD
Pasireotide—Hypokalaemia—Cisplatin—germ cell cancer	0.0024	0.0155	CcSEcCtD
Pasireotide—Hyperglycaemia—Ifosfamide—germ cell cancer	0.00238	0.0154	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Cisplatin—germ cell cancer	0.00237	0.0153	CcSEcCtD
Pasireotide—Anaemia—Vinblastine—germ cell cancer	0.00236	0.0152	CcSEcCtD
Pasireotide—Nasopharyngitis—Cisplatin—germ cell cancer	0.00236	0.0152	CcSEcCtD
Pasireotide—Vertigo—Vinblastine—germ cell cancer	0.00229	0.0148	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—OXT—germ cell cancer	0.00228	0.0124	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.00223	0.0121	CbGpPWpGaD
Pasireotide—Hypertension—Vinblastine—germ cell cancer	0.0022	0.0142	CcSEcCtD
Pasireotide—Alopecia—Bleomycin—germ cell cancer	0.00219	0.0141	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Etoposide—germ cell cancer	0.00213	0.0137	CcSEcCtD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.00206	0.0111	CbGpPWpGaD
Pasireotide—Alopecia—Dactinomycin—germ cell cancer	0.00204	0.0131	CcSEcCtD
Pasireotide—SSTR3—GPCR ligand binding—AVP—germ cell cancer	0.00199	0.0108	CbGpPWpGaD
Pasireotide—Anaemia—Bleomycin—germ cell cancer	0.00199	0.0128	CcSEcCtD
Pasireotide—SSTR1—GPCR ligand binding—AVP—germ cell cancer	0.00191	0.0104	CbGpPWpGaD
Pasireotide—Alopecia—Ifosfamide—germ cell cancer	0.00187	0.012	CcSEcCtD
Pasireotide—Anaemia—Dactinomycin—germ cell cancer	0.00186	0.012	CcSEcCtD
Pasireotide—Myalgia—Bleomycin—germ cell cancer	0.00183	0.0118	CcSEcCtD
Pasireotide—Decreased appetite—Vinblastine—germ cell cancer	0.00181	0.0117	CcSEcCtD
Pasireotide—Constipation—Vinblastine—germ cell cancer	0.00178	0.0115	CcSEcCtD
Pasireotide—Myalgia—Dactinomycin—germ cell cancer	0.00171	0.011	CcSEcCtD
Pasireotide—Gastrointestinal pain—Vinblastine—germ cell cancer	0.0017	0.011	CcSEcCtD
Pasireotide—Anaemia—Ifosfamide—germ cell cancer	0.0017	0.011	CcSEcCtD
Pasireotide—SSTR5—GPCR ligand binding—AVP—germ cell cancer	0.0017	0.00918	CbGpPWpGaD
Pasireotide—Diabetes mellitus—Methotrexate—germ cell cancer	0.00166	0.0107	CcSEcCtD
Pasireotide—Vertigo—Ifosfamide—germ cell cancer	0.00165	0.0107	CcSEcCtD
Pasireotide—Abdominal pain—Vinblastine—germ cell cancer	0.00164	0.0106	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—OXT—germ cell cancer	0.00164	0.00891	CbGpPWpGaD
Pasireotide—Hypotension—Bleomycin—germ cell cancer	0.00164	0.0106	CcSEcCtD
Pasireotide—Alopecia—Cisplatin—germ cell cancer	0.00161	0.0104	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.0016	0.0103	CcSEcCtD
Pasireotide—Hypertension—Ifosfamide—germ cell cancer	0.00159	0.0102	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—OXT—germ cell cancer	0.00158	0.00854	CbGpPWpGaD
Pasireotide—Arthralgia—Ifosfamide—germ cell cancer	0.00157	0.0101	CcSEcCtD
Pasireotide—Myalgia—Ifosfamide—germ cell cancer	0.00157	0.0101	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—AVP—germ cell cancer	0.00157	0.00848	CbGpPWpGaD
Pasireotide—Decreased appetite—Bleomycin—germ cell cancer	0.00153	0.00985	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—OXT—germ cell cancer	0.00149	0.00809	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00149	0.00963	CcSEcCtD
Pasireotide—Asthenia—Vinblastine—germ cell cancer	0.00149	0.00963	CcSEcCtD
Pasireotide—Alopecia—Etoposide—germ cell cancer	0.00148	0.00951	CcSEcCtD
Pasireotide—Anaemia—Cisplatin—germ cell cancer	0.00147	0.00945	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—OXT—germ cell cancer	0.00143	0.00775	CbGpPWpGaD
Pasireotide—Decreased appetite—Dactinomycin—germ cell cancer	0.00142	0.00919	CcSEcCtD
Pasireotide—Diarrhoea—Vinblastine—germ cell cancer	0.00142	0.00918	CcSEcCtD
Pasireotide—Fatigue—Dactinomycin—germ cell cancer	0.00141	0.00911	CcSEcCtD
Pasireotide—Back pain—Etoposide—germ cell cancer	0.00141	0.00906	CcSEcCtD
Pasireotide—Hypotension—Ifosfamide—germ cell cancer	0.0014	0.00905	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—OXT—germ cell cancer	0.0014	0.00757	CbGpPWpGaD
Pasireotide—Dizziness—Vinblastine—germ cell cancer	0.00138	0.00887	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00137	0.00882	CcSEcCtD
Pasireotide—Myalgia—Cisplatin—germ cell cancer	0.00135	0.00871	CcSEcCtD
Pasireotide—Anxiety—Cisplatin—germ cell cancer	0.00135	0.00868	CcSEcCtD
Pasireotide—Anaemia—Etoposide—germ cell cancer	0.00134	0.00866	CcSEcCtD
Pasireotide—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00134	0.00864	CcSEcCtD
Pasireotide—Vomiting—Vinblastine—germ cell cancer	0.00132	0.00853	CcSEcCtD
Pasireotide—Vertigo—Etoposide—germ cell cancer	0.00131	0.00842	CcSEcCtD
Pasireotide—Decreased appetite—Ifosfamide—germ cell cancer	0.00131	0.00842	CcSEcCtD
Pasireotide—Headache—Vinblastine—germ cell cancer	0.0013	0.0084	CcSEcCtD
Pasireotide—Abdominal pain—Dactinomycin—germ cell cancer	0.0013	0.00835	CcSEcCtD
Pasireotide—Fatigue—Ifosfamide—germ cell cancer	0.00129	0.00835	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—OXT—germ cell cancer	0.00129	0.00699	CbGpPWpGaD
Pasireotide—Constipation—Ifosfamide—germ cell cancer	0.00128	0.00828	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—OXT—germ cell cancer	0.00127	0.00688	CbGpPWpGaD
Pasireotide—Asthenia—Bleomycin—germ cell cancer	0.00126	0.00813	CcSEcCtD
Pasireotide—Hypertension—Etoposide—germ cell cancer	0.00125	0.00809	CcSEcCtD
Pasireotide—Pruritus—Bleomycin—germ cell cancer	0.00124	0.00802	CcSEcCtD
Pasireotide—Nausea—Vinblastine—germ cell cancer	0.00124	0.00797	CcSEcCtD
Pasireotide—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00123	0.00792	CcSEcCtD
Pasireotide—Hypotension—Cisplatin—germ cell cancer	0.00121	0.0078	CcSEcCtD
Pasireotide—Abdominal pain—Ifosfamide—germ cell cancer	0.00119	0.00766	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00118	0.00761	CcSEcCtD
Pasireotide—Asthenia—Dactinomycin—germ cell cancer	0.00118	0.00758	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—OXT—germ cell cancer	0.00117	0.00635	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—AVP—germ cell cancer	0.00113	0.0061	CbGpPWpGaD
Pasireotide—Decreased appetite—Cisplatin—germ cell cancer	0.00113	0.00726	CcSEcCtD
Pasireotide—Diarrhoea—Dactinomycin—germ cell cancer	0.00112	0.00723	CcSEcCtD
Pasireotide—Vomiting—Bleomycin—germ cell cancer	0.00112	0.0072	CcSEcCtD
Pasireotide—Hypotension—Etoposide—germ cell cancer	0.00111	0.00715	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—AVP—germ cell cancer	0.00108	0.00585	CbGpPWpGaD
Pasireotide—Asthenia—Ifosfamide—germ cell cancer	0.00108	0.00695	CcSEcCtD
Pasireotide—Pruritus—Ifosfamide—germ cell cancer	0.00106	0.00685	CcSEcCtD
Pasireotide—Nausea—Bleomycin—germ cell cancer	0.00104	0.00673	CcSEcCtD
Pasireotide—Vomiting—Dactinomycin—germ cell cancer	0.00104	0.00672	CcSEcCtD
Pasireotide—Decreased appetite—Etoposide—germ cell cancer	0.00103	0.00665	CcSEcCtD
Pasireotide—Diarrhoea—Ifosfamide—germ cell cancer	0.00103	0.00663	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—AVP—germ cell cancer	0.00102	0.00554	CbGpPWpGaD
Pasireotide—Fatigue—Etoposide—germ cell cancer	0.00102	0.00659	CcSEcCtD
Pasireotide—Constipation—Etoposide—germ cell cancer	0.00101	0.00654	CcSEcCtD
Pasireotide—Dizziness—Ifosfamide—germ cell cancer	0.000993	0.0064	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—AVP—germ cell cancer	0.000981	0.00531	CbGpPWpGaD
Pasireotide—Nausea—Dactinomycin—germ cell cancer	0.000973	0.00628	CcSEcCtD
Pasireotide—Gastrointestinal pain—Etoposide—germ cell cancer	0.00097	0.00625	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—AVP—germ cell cancer	0.000958	0.00519	CbGpPWpGaD
Pasireotide—Vomiting—Ifosfamide—germ cell cancer	0.000955	0.00616	CcSEcCtD
Pasireotide—Abdominal pain—Etoposide—germ cell cancer	0.000938	0.00605	CcSEcCtD
Pasireotide—Asthenia—Cisplatin—germ cell cancer	0.000929	0.00599	CcSEcCtD
Pasireotide—Nausea—Ifosfamide—germ cell cancer	0.000892	0.00575	CcSEcCtD
Pasireotide—Diarrhoea—Cisplatin—germ cell cancer	0.000886	0.00571	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—AVP—germ cell cancer	0.000885	0.00479	CbGpPWpGaD
Pasireotide—Alopecia—Methotrexate—germ cell cancer	0.000884	0.0057	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—OXT—germ cell cancer	0.000882	0.00478	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—AVP—germ cell cancer	0.00087	0.00471	CbGpPWpGaD
Pasireotide—Asthenia—Etoposide—germ cell cancer	0.000851	0.00549	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—OXT—germ cell cancer	0.000846	0.00458	CbGpPWpGaD
Pasireotide—Back pain—Methotrexate—germ cell cancer	0.000842	0.00543	CcSEcCtD
Pasireotide—Pruritus—Etoposide—germ cell cancer	0.000839	0.00541	CcSEcCtD
Pasireotide—Vomiting—Cisplatin—germ cell cancer	0.000823	0.00531	CcSEcCtD
Pasireotide—Diarrhoea—Etoposide—germ cell cancer	0.000812	0.00523	CcSEcCtD
Pasireotide—Anaemia—Methotrexate—germ cell cancer	0.000805	0.00519	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—AVP—germ cell cancer	0.000803	0.00435	CbGpPWpGaD
Pasireotide—Dizziness—Etoposide—germ cell cancer	0.000784	0.00506	CcSEcCtD
Pasireotide—Vertigo—Methotrexate—germ cell cancer	0.000782	0.00504	CcSEcCtD
Pasireotide—Nausea—Cisplatin—germ cell cancer	0.000769	0.00496	CcSEcCtD
Pasireotide—Vomiting—Etoposide—germ cell cancer	0.000754	0.00486	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—FGF4—germ cell cancer	0.000753	0.00408	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—OXT—germ cell cancer	0.00075	0.00406	CbGpPWpGaD
Pasireotide—Headache—Etoposide—germ cell cancer	0.000743	0.00479	CcSEcCtD
Pasireotide—Myalgia—Methotrexate—germ cell cancer	0.000741	0.00478	CcSEcCtD
Pasireotide—Arthralgia—Methotrexate—germ cell cancer	0.000741	0.00478	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—FGF4—germ cell cancer	0.000722	0.00391	CbGpPWpGaD
Pasireotide—Nausea—Etoposide—germ cell cancer	0.000705	0.00454	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—OXT—germ cell cancer	0.000692	0.00375	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—H2AFZ—germ cell cancer	0.000672	0.00364	CbGpPWpGaD
Pasireotide—Hypotension—Methotrexate—germ cell cancer	0.000664	0.00428	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000647	0.00417	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—H2AFZ—germ cell cancer	0.000645	0.00349	CbGpPWpGaD
Pasireotide—Insomnia—Methotrexate—germ cell cancer	0.000643	0.00414	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—FGF4—germ cell cancer	0.00064	0.00347	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—KITLG—germ cell cancer	0.000619	0.00335	CbGpPWpGaD
Pasireotide—Decreased appetite—Methotrexate—germ cell cancer	0.000618	0.00398	CcSEcCtD
Pasireotide—Fatigue—Methotrexate—germ cell cancer	0.000613	0.00395	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—AVP—germ cell cancer	0.000605	0.00327	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—KITLG—germ cell cancer	0.000593	0.00321	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FGF4—germ cell cancer	0.000591	0.0032	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000581	0.00375	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—AVP—germ cell cancer	0.00058	0.00314	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—H2AFZ—germ cell cancer	0.000572	0.0031	CbGpPWpGaD
Pasireotide—Abdominal pain—Methotrexate—germ cell cancer	0.000562	0.00362	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—H2AFZ—germ cell cancer	0.000528	0.00286	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KITLG—germ cell cancer	0.000526	0.00285	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—AVP—germ cell cancer	0.000514	0.00278	CbGpPWpGaD
Pasireotide—Asthenia—Methotrexate—germ cell cancer	0.00051	0.00329	CcSEcCtD
Pasireotide—Pruritus—Methotrexate—germ cell cancer	0.000503	0.00324	CcSEcCtD
Pasireotide—Diarrhoea—Methotrexate—germ cell cancer	0.000486	0.00313	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—KITLG—germ cell cancer	0.000485	0.00263	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—AVP—germ cell cancer	0.000474	0.00257	CbGpPWpGaD
Pasireotide—Dizziness—Methotrexate—germ cell cancer	0.00047	0.00303	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—FGFR3—germ cell cancer	0.00046	0.00249	CbGpPWpGaD
Pasireotide—Vomiting—Methotrexate—germ cell cancer	0.000452	0.00291	CcSEcCtD
Pasireotide—Headache—Methotrexate—germ cell cancer	0.000445	0.00287	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—FGFR3—germ cell cancer	0.000441	0.00239	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—KIT—germ cell cancer	0.000422	0.00229	CbGpPWpGaD
Pasireotide—Nausea—Methotrexate—germ cell cancer	0.000422	0.00272	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—KIT—germ cell cancer	0.000405	0.00219	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—FGFR3—germ cell cancer	0.000391	0.00212	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FGFR3—germ cell cancer	0.000361	0.00195	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KIT—germ cell cancer	0.000359	0.00194	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—KIT—germ cell cancer	0.000331	0.00179	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—HRAS—germ cell cancer	0.000309	0.00167	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—HRAS—germ cell cancer	0.000296	0.0016	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—HRAS—germ cell cancer	0.000263	0.00142	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—HRAS—germ cell cancer	0.000242	0.00131	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MYC—germ cell cancer	0.000232	0.00126	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MYC—germ cell cancer	0.000223	0.00121	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MYC—germ cell cancer	0.000198	0.00107	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TP53—germ cell cancer	0.000191	0.00103	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TP53—germ cell cancer	0.000183	0.00099	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HRAS—germ cell cancer	0.000182	0.000988	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MYC—germ cell cancer	0.000182	0.000987	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HRAS—germ cell cancer	0.000175	0.000947	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TP53—germ cell cancer	0.000162	0.000878	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HRAS—germ cell cancer	0.000155	0.00084	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TP53—germ cell cancer	0.00015	0.000811	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HRAS—germ cell cancer	0.000143	0.000775	CbGpPWpGaD
